Prognostic significance of blood pressure variability after thrombolysis in acute stroke

Neurology

Volumn 71, Issue 8, 2008, Pages 552-558

  Delgado Mederos, R ^a   Ribo, M ^a   Rovira, A ^a   Rubiera, M ^a   Munuera, J ^a   Santamarina, E ^a   Delgado, P ^a   Maisterra, O ^a   Alvarez Sabin, J ^a   Molina, C A ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CLINICAL ASSESSMENT; CLINICAL TRIAL; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DIFFUSION WEIGHTED IMAGING; DOPPLER ECHOGRAPHY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFORMED CONSENT; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; OUTCOME ASSESSMENT; PATIENT INFORMATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANKIN SCALE; RECANALIZATION; RISK FACTOR; STROKE; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME; ACUTE DISEASE; BLOOD PRESSURE; CEREBRAL ARTERY DISEASE; DIASTOLE; DISEASE COURSE; DRUG EFFECT; FIBRINOLYTIC THERAPY; METHODOLOGY; PREDICTION AND FORECASTING; REGRESSION ANALYSIS; SYSTOLE;

ACUTE DISEASE; AGED; BLOOD PRESSURE; DIASTOLE; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; STROKE; SYSTOLE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 54749116055     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000318294.36223.69     Document Type: Article

References (16)

1. NINDS rt-PA Stroke Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333: 1581-1587.
2. Tanne D, Kasner SE, Demchuk AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002;105:1679-1685.
3. Brott T, Lu M, Kothari R, et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke 1998; 29:1504-1509.
4. Powers WJ. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 1993;43:461- 467.
5. Adams HP Jr., Adams RJ, Brott T, et al. , Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056-1083.
6. Burgin WS, Malkoff M, Demchuk AM, et al. Transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke 2000;3: 1128-1132.
7. Demchuk AM, Burgin WS, Christou I, et al. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001;32:89-93.
8. Arenillas JF, Rovira A, Molina CA, Grive E, Montaner J, Alvarez-Sabin J. Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke 2002;33:2197-2203.
9. Willmot M, Leonardi-Bee J, Bath PMW. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004;43:18-24.
10. Mattle HP, Kappeler L, Arnold M, et al. Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 2005;36:264-268.
11. Dawson SL, Manktelow BN, Robinson TG, Panerai RB, Potter JF. Which parameters of beat-to-beat blood pressure and variability best predict early outcome after acute ischemic stroke? Stroke 2000;31:463-468.
12. Stead LG, Gilmore RM, Vedula KC, Weaver AL, Decker WW, Brown RD. Impact of acute blood pressure variability on ischemic stroke outcome. Neurology 2006;66:1878-1881.
13. Robinson T, James M, Youde J, Panerai R, Potter J. Cardiac baroreceptor sensitivity is impaired after acute stroke. Stroke 1997;28:1671-1676.
14. Fassbender K, Schmidt R, Mobner R, Daffertshofer M, Hennerici M. Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Stroke 1994;6:1105-1108.
15. Rordorf G, Koroshetz WJ, Ezzeddine MA, Segal AZ, Buonanno FS. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 2001;56: 1210-1213.
16. Hillis AE, Ulatowski JA, Barker PB, et al. A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis 2003;16:236- 246.